124 related articles for article (PubMed ID: 32027127)
21. Phosphorylation of elongation factor-2 kinase on serine 499 by cAMP-dependent protein kinase induces Ca2+/calmodulin-independent activity.
Diggle TA; Subkhankulova T; Lilley KS; Shikotra N; Willis AE; Redpath NT
Biochem J; 2001 Feb; 353(Pt 3):621-6. PubMed ID: 11171059
[TBL] [Abstract][Full Text] [Related]
22. Solution Structure of the Carboxy-Terminal Tandem Repeat Domain of Eukaryotic Elongation Factor 2 Kinase and Its Role in Substrate Recognition.
Piserchio A; Will N; Giles DH; Hajredini F; Dalby KN; Ghose R
J Mol Biol; 2019 Jul; 431(15):2700-2717. PubMed ID: 31108082
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of elongation factor-2 kinase differentially regulates the enzyme's stability under stress conditions.
Huber-Keener KJ; Evans BR; Ren X; Cheng Y; Zhang Y; Hait WN; Yang JM
Biochem Biophys Res Commun; 2012 Jul; 424(2):308-14. PubMed ID: 22749997
[TBL] [Abstract][Full Text] [Related]
24. Regulation of elongation factor-2 kinase by pH.
Dorovkov MV; Pavur KS; Petrov AN; Ryazanov AG
Biochemistry; 2002 Nov; 41(45):13444-50. PubMed ID: 12416990
[TBL] [Abstract][Full Text] [Related]
25. eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis.
Cheng Y; Ren X; Yuan Y; Shan Y; Li L; Chen X; Zhang L; Takahashi Y; Yang JW; Han B; Liao J; Li Y; Harvey H; Ryazanov A; Robertson GP; Wan G; Liu D; Chen AF; Tao Y; Yang JM
Oncogene; 2016 Dec; 35(49):6293-6308. PubMed ID: 27181208
[TBL] [Abstract][Full Text] [Related]
26. Regulation of protein-synthesis elongation-factor-2 kinase by cAMP in adipocytes.
Diggle TA; Redpath NT; Heesom KJ; Denton RM
Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):525-9. PubMed ID: 9841860
[TBL] [Abstract][Full Text] [Related]
27. High-throughput screens for eEF-2 kinase.
Devkota AK; Warthaka M; Edupuganti R; Tavares CD; Johnson WH; Ozpolat B; Cho EJ; Dalby KN
J Biomol Screen; 2014 Mar; 19(3):445-52. PubMed ID: 24078616
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the domain structure of elongation factor-2 kinase by mutagenesis.
Diggle TA; Seehra CK; Hase S; Redpath NT
FEBS Lett; 1999 Aug; 457(2):189-92. PubMed ID: 10471776
[TBL] [Abstract][Full Text] [Related]
29. Modified gold-based siRNA nanotherapeutics for targeted therapy of triple-negative breast cancer.
Shahbazi R; Asik E; Kahraman N; Turk M; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2017 Aug; 12(16):1961-1973. PubMed ID: 28745127
[TBL] [Abstract][Full Text] [Related]
30. A critical role of eEF-2K in mediating autophagy in response to multiple cellular stresses.
Py BF; Boyce M; Yuan J
Autophagy; 2009 Apr; 5(3):393-6. PubMed ID: 19221463
[TBL] [Abstract][Full Text] [Related]
31. Structure of the C-Terminal Helical Repeat Domain of Eukaryotic Elongation Factor 2 Kinase.
Will N; Piserchio A; Snyder I; Ferguson SB; Giles DH; Dalby KN; Ghose R
Biochemistry; 2016 Sep; 55(38):5377-86. PubMed ID: 27571275
[TBL] [Abstract][Full Text] [Related]
32. Elongation factor-2 kinase is a critical determinant of the fate and antitumor immunity of CD8
Das JK; Ren Y; Kumar A; Peng HY; Wang L; Xiong X; Alaniz RC; de Figueiredo P; Ren X; Liu X; Ryazonov AG; Yang JM; Song J
Sci Adv; 2022 Feb; 8(5):eabl9783. PubMed ID: 35108044
[TBL] [Abstract][Full Text] [Related]
33. Structural Dynamics of the Activation of Elongation Factor 2 Kinase by Ca
Will N; Lee K; Hajredini F; Giles DH; Abzalimov RR; Clarkson M; Dalby KN; Ghose R
J Mol Biol; 2018 Aug; 430(17):2802-2821. PubMed ID: 29800565
[TBL] [Abstract][Full Text] [Related]
34. Structural Basis for the Recognition of Eukaryotic Elongation Factor 2 Kinase by Calmodulin.
Lee K; Alphonse S; Piserchio A; Tavares CD; Giles DH; Wellmann RM; Dalby KN; Ghose R
Structure; 2016 Sep; 24(9):1441-51. PubMed ID: 27499441
[TBL] [Abstract][Full Text] [Related]
35. Transient up-regulation of elongation factor-2 kinase (Ca2+/calmodulin-dependent protein kinase III) messenger RNA in developing mouse brain.
Sakagami H; Nishimura H; Saito R; Kondo H
Neurosci Lett; 2002 Sep; 330(1):41-4. PubMed ID: 12213630
[TBL] [Abstract][Full Text] [Related]
36. Revealing eEF-2 kinase: recent structural insights into function.
Piserchio A; Dalby KN; Ghose R
Trends Biochem Sci; 2024 Feb; 49(2):169-182. PubMed ID: 38103971
[TBL] [Abstract][Full Text] [Related]
37. Cloning and expression of cDNA encoding protein synthesis elongation factor-2 kinase.
Redpath NT; Price NT; Proud CG
J Biol Chem; 1996 Jul; 271(29):17547-54. PubMed ID: 8663182
[TBL] [Abstract][Full Text] [Related]
38. A pharmacoproteomic approach implicates eukaryotic elongation factor 2 kinase in ER stress-induced cell death.
Boyce M; Py BF; Ryazanov AG; Minden JS; Long K; Ma D; Yuan J
Cell Death Differ; 2008 Mar; 15(3):589-99. PubMed ID: 18188169
[TBL] [Abstract][Full Text] [Related]
39. Structural basis for the calmodulin-mediated activation of eukaryotic elongation factor 2 kinase.
Piserchio A; Isiorho EA; Long K; Bohanon AL; Kumar EA; Will N; Jeruzalmi D; Dalby KN; Ghose R
Sci Adv; 2022 Jul; 8(27):eabo2039. PubMed ID: 35857468
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of an inhibitor of eukaryotic elongation factor 2 kinase against human cancer cell lines.
Arora S; Yang JM; Kinzy TG; Utsumi R; Okamoto T; Kitayama T; Ortiz PA; Hait WN
Cancer Res; 2003 Oct; 63(20):6894-9. PubMed ID: 14583488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]